NCT00433485View on ClinicalTrials.gov

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

Not specified

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Neoplastic SyndromeNon-melanomatous Skin Cancer
Interventions
DRUG

sirolimus

GENETIC

comparative genomic hybridization

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

protein expression analysis

GENETIC

proteomic profiling

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

PROCEDURE

biopsy

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT00433485 - Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants | Biotech Hunter | Biotech Hunter